Abstract
The occurrence of sarcoidosis during anti-TNF-alpha therapy has occasionally been published. We report the case of a psoriasis patient who developed pulmonary sarcoidosis during a cycle of therapy with infliximab.
MeSH terms
-
Adult
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antirheumatic Agents / administration & dosage
-
Antirheumatic Agents / adverse effects*
-
Arthritis, Psoriatic / drug therapy*
-
Humans
-
Infliximab
-
Infusions, Intravenous
-
Male
-
Sarcoidosis, Pulmonary / chemically induced*
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab